Medicine & Life Sciences
Breast Neoplasms
100%
Neoplasms
46%
Transforming Growth Factors
34%
ErbB Receptors
30%
Trastuzumab
26%
Phosphatidylinositol 3-Kinase
26%
Estrogen Receptors
22%
Protein-Tyrosine Kinases
21%
Phosphatidylinositol 3-Kinases
19%
Mutation
18%
Breast
17%
Phosphotransferases
16%
Estrogen Receptor Modulators
16%
Therapeutics
15%
human ERBB2 protein
15%
Letrozole
15%
Triple Negative Breast Neoplasms
15%
Growth
15%
Lapatinib
14%
Estrogens
13%
Ligands
12%
Disclosure
12%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
12%
Fulvestrant
11%
Hormones
11%
Heterografts
10%
ribociclib
10%
Tamoxifen
9%
Epithelial Cells
9%
Phosphorylation
9%
Alpelisib
9%
Oncogenes
8%
NVP-BKM120
8%
Pharmaceutical Preparations
8%
Biomarkers
8%
Growth Factor Receptors
8%
Cell Line
8%
Emotions
7%
Gefitinib
7%
Foster Home Care
7%
Antibodies
7%
Receptor Protein-Tyrosine Kinases
6%
Mitogen-Activated Protein Kinase Kinases
6%
3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
6%
Cell Movement
6%
Carcinogenesis
6%
Neoplasm Metastasis
6%
Drug Therapy
6%
MCF-7 Cells
6%
Down-Regulation
5%